Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
TNF Pharmaceuticals ( (TNFA) ) just unveiled an update.
At the recent Annual Meeting, TNF Pharmaceuticals, Inc. saw the election of seven directors to its board, approval of an amendment to its 2021 Equity Incentive Plan increasing available shares for awards, and the ratification of Stephano Slack LLC as its independent auditor for 2024. Additionally, a proposal to potentially adjourn the meeting for further proxy votes was approved, reflecting robust shareholder participation and engagement in the company’s governance.
See more data about TNFA stock on TipRanks’ Stock Analysis page.
Trending Articles
- BTCC, WGMI: 2 Bitcoin ETFs for Crypto Exposure
- Shareholder Alert for PACS Group, Inc. (NYSE:PACS)
- Netflix Wins Shareholder Lawsuit Alleging Misleading Growth Forecasts
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
